Caspases and therapeutic potential of caspase inhibitors in moderate-severe SARS-CoV-2 infection and long COVID.
Allergy
; 77(1): 118-129, 2022 01.
Article
in En
| MEDLINE
| ID: mdl-33993490
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Caspase Inhibitors
/
COVID-19
/
COVID-19 Drug Treatment
Limits:
Humans
Language:
En
Journal:
Allergy
Year:
2022
Document type:
Article
Affiliation country:
United States
Country of publication:
Denmark